Disclosure Of Fair Value Measurement [Text Block]
| Concept |
As at 2024-12-31 |
As at 2024-12-31 |
As at 2024-12-31 |
As at 2024-12-31 |
2024-01-01 to 2024-12-31 |
As at 2024-12-31 |
As at 2024-12-31 |
As at 2023-12-31 |
As at 2023-12-31 |
As at 2023-12-31 |
As at 2023-12-31 |
As at 2023-12-31 |
As at 2023-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
As at 2022-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Disclosure of fair value measurement [text block] | — | — | — | — |
Biological
|
— | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Disclosure of fair value measurement of assets [text block] | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Disclosure of fair value measurement of assets [abstract] | |||||||||||||||||||
| Disclosure of fair value measurement of assets [line items] | |||||||||||||||||||
| Assets | — | — | — | — | — | — |
273,673,000
USD
|
342,258,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Reconciliation of changes in fair value measurement, assets [abstract] | |||||||||||||||||||
| Disclosure of fair value measurement of liabilities [text block] | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Disclosure of fair value measurement of liabilities [abstract] | |||||||||||||||||||
| Disclosure of fair value measurement of liabilities [line items] | |||||||||||||||||||
| Liabilities | — | — | — | — | — | — |
70,841,000
USD
|
59,118,000
USD
|
— | — | — | — | — | — | — | — | — | — | — |
| Reconciliation of changes in fair value measurement, liabilities [abstract] | |||||||||||||||||||
| Disclosure of fair value measurement of equity [text block] | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Disclosure of fair value measurement of equity [abstract] | |||||||||||||||||||
| Disclosure of fair value measurement of equity [line items] | |||||||||||||||||||
| Equity |
581,488,000
USD
|
751,560,000
USD
|
38,110,000
USD
|
9,454,000
USD
|
— |
4,104,000
USD
|
202,832,000
USD
|
283,140,000
USD
|
414,167,000
USD
|
691,430,000
USD
|
6,726,000
USD
|
8,644,000
USD
|
3,959,000
USD
|
296,382,000
USD
|
577,805,000
USD
|
4,319,000
USD
|
280,409,000
USD
|
1,716,000
USD
|
7,049,000
USD
|
| Reconciliation of changes in fair value measurement, entity's own equity instruments [abstract] |